Back to Search
Start Over
Sequential combination of thalidomide and erythropoietin determines transfusion independence and disease control in idiopathic myelofibrosis previously insensitive to both drugs used as single agents
- Source :
- Leukemia. 17:1669-1670
- Publication Year :
- 2003
- Publisher :
- Springer Science and Business Media LLC, 2003.
-
Abstract
- Sequential combination of thalidomide and erythropoietin determines transfusion independence and disease control in idiopathic myelofibrosis previously insensitive to both drugs used as single agents
Details
- ISSN :
- 14765551 and 08876924
- Volume :
- 17
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi...........0ac6984ce8c5d8e1daef9d22293517c6
- Full Text :
- https://doi.org/10.1038/sj.leu.2403017